Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
BMJ
    July 2021

  1. Nutritional basis of type 2 diabetes remission.
    BMJ. 2021;374:n1752.
    >> Share

  2. TAYLOR R, Ramachandran A, Yancy WS Jr, Forouhi NG, et al
    Nutritional basis of type 2 diabetes remission.
    BMJ. 2021;374:n1449.
    >> Share

    June 2021
  3. IACOBUCCI G
    NHS to trial "artificial pancreas" for patients with type 1 diabetes.
    BMJ. 2021;373:n1538.
    >> Share

    May 2021
  4. FREY E, Bonfiglioli C, Frawley J
    Self-management: diabetes care is getting social.
    BMJ. 2021;373:n1333.
    >> Share


  5. Newer drug treatments for type 2 diabetes.
    BMJ. 2021;373:n1326.
    >> Share

  6. GOLDENBERG JZ, Johnston BC
    Low and very low carbohydrate diets for diabetes remission.
    BMJ. 2021;373:n262.
    >> Share

  7. WISE J
    Diabetes: BMI cut-offs designed to trigger action are too high for some ethnic populations, say researchers.
    BMJ. 2021;373:n1217.
    >> Share

  8. LI S, Vandvik PO, Lytvyn L, Guyatt GH, et al
    SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.
    BMJ. 2021;373:n1091.
    >> Share

  9. GUO J, Smith SM
    Newer drug treatments for type 2 diabetes.
    BMJ. 2021;373:n1171.
    >> Share

  10. NASIR K, Cainzos-Achirica M
    Role of coronary artery calcium score in the primary prevention of cardiovascular disease.
    BMJ. 2021;373:n776.
    >> Share

    March 2021
  11. CASASSUS B
    Drug company Servier is found guilty of manslaughter and aggravated deceit over Mediator diabetes drug.
    BMJ. 2021;372:n873.
    >> Share

  12. AYOUBKHANI D, Khunti K, Nafilyan V, Maddox T, et al
    Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study.
    BMJ. 2021;372:n693.
    >> Share

  13. JONES A, Wu JHY, Buse K
    UK's sugar tax hits the sweet spot.
    BMJ. 2021;372:n463.
    >> Share

    January 2021
  14. PALMER SC, Tendal B, Mustafa RA, Vandvik PO, et al
    Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2021;372:m4573.
    >> Share

  15. GOLDENBERG JZ, Day A, Brinkworth GD, Sato J, et al
    Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data.
    BMJ. 2021;372:m4743.
    >> Share

  16. DOWNS J
    Please see the whole picture of my eating disorder.
    BMJ. 2021;372:m4569.
    >> Share

    December 2020
  17. DELICANO RA, Hammar U, Egenvall A, Westgarth C, et al
    The shared risk of diabetes between dog and cat owners and their pets: register based cohort study.
    BMJ. 2020;371:m4337.
    >> Share

    November 2020
  18. IACOBUCCI G
    Every hospital should have a specialist diabetes inpatient team, says review.
    BMJ. 2020;371:m4441.
    >> Share

  19. MUSSO G, Saba F, Cassader M, Gambino R, et al
    Diabetic ketoacidosis with SGLT2 inhibitors.
    BMJ. 2020;371:m4147.
    >> Share

    September 2020
  20. HILL NE, Oliver NS
    Evolving type 1 diabetes in distinguishing between type 1 and type 2 diabetes.
    BMJ. 2020;370:m3772.
    >> Share

  21. FILION KB, Lix LM, Yu OH, Dell'Aniello S, et al
    Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.
    BMJ. 2020;370:m3342.
    >> Share

    August 2020
  22. FRALICK M, Kim SC, Schneeweiss S, Everett BM, et al
    Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study.
    BMJ. 2020;370:m2812.
    >> Share

  23. BUTLER AE, Misselbrook D
    Distinguishing between type 1 and type 2 diabetes.
    BMJ. 2020;370:m2998.
    >> Share

    July 2020
  24. CAI X, Zhang Y, Li M, Wu JH, et al
    Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.
    BMJ. 2020;370:m2297.
    >> Share

  25. HU Y, Ding M, Sampson L, Willett WC, et al
    Intake of whole grain foods and risk of type 2 diabetes: results from three prospective cohort studies.
    BMJ. 2020;370:m2206.
    >> Share

  26. ZHENG JS, Sharp SJ, Imamura F, Chowdhury R, et al
    Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countries.
    BMJ. 2020;370:m2194.
    >> Share

  27. BURNS VF
    I live with "the world's most dangerous" eating disorder.
    BMJ. 2020;370:m1886.
    >> Share

    June 2020
  28. MCMILLAN B, Boyd J, Mitchell C
    Enhancing postnatal care of women with gestational diabetes.
    BMJ. 2020;369:m2414.
    >> Share

  29. KAR P
    Partha Kar: Covid-19-time for parity in commissioning diabetes services.
    BMJ. 2020;369:m2154.
    >> Share

    May 2020
  30. VOUNZOULAKI E, Khunti K, Abner SC, Tan BK, et al
    Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis.
    BMJ. 2020;369:m1361.
    >> Share

  31. RICHARDSON TG, Sanderson E, Elsworth B, Tilling K, et al
    Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study.
    BMJ. 2020;369:m1203.
    >> Share

    April 2020
  32. BHASALE A, Mintzes B, Sarpatwari A
    Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators.
    BMJ. 2020;369:m1107.
    >> Share

  33. PASTERNAK B, Wintzell V, Melbye M, Eliasson B, et al
    Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study.
    BMJ. 2020;369:m1186.
    >> Share

  34. LI Y, Teng D, Shi X, Qin G, et al
    Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study.
    BMJ. 2020;369:m997.
    >> Share

  35. MATHIESON S, Lin CC, Underwood M, Eldabe S, et al
    Pregabalin and gabapentin for pain.
    BMJ. 2020;369:m1315.
    >> Share

  36. DIAB J, Bannan A, Pollitt T
    Necrotising fasciitis.
    BMJ. 2020;369:m1428.
    >> Share

    March 2020

  37. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
    BMJ. 2020;368:m1270.
    >> Share

  38. IACOBUCCI G
    Covid-19: diabetes clinicians set up social media account to help alleviate patients' fears.
    BMJ. 2020;368:m1262.
    >> Share

  39. EXTANCE A
    Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
    BMJ. 2020;368:m1174.
    >> Share

  40. VALABHJI J
    Rapid access to multidisciplinary diabetes foot care teams.
    BMJ. 2020;368:m773.
    >> Share

    February 2020
  41. MCCORMACK JP, Holmes DT
    Your results may vary: the imprecision of medical measurements.
    BMJ. 2020;368:m149.
    >> Share

  42. ROY MP
    Improving nutrition in India: encouraging informed food choices.
    BMJ. 2020;368:m367.
    >> Share

  43. VAN DUINEN GL
    Healthy lifestyle and life expectancy: fund prevention programmes to end the cycle of preventable morbidity.
    BMJ. 2020;368:m427.
    >> Share

  44. CRAIG MF
    We shouldn't recommend harmful foods "in moderation".
    BMJ. 2020;368:m365.
    >> Share

    January 2020
  45. FEINMANN J
    Hope for diabetes: five minutes with David Unwin.
    BMJ. 2020;368:m404.
    >> Share

  46. COOK R, Davidson P, Martin R
    Losing weight following diagnosis of type 2 diabetes boosts chance of remission.
    BMJ. 2020;368:l6775.
    >> Share

  47. KAR P
    Partha Kar: What will the 2020s hold for diabetes care?
    BMJ. 2020;368:m202.
    >> Share

  48. LI Y, Schoufour J, Wang DD, Dhana K, et al
    Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study.
    BMJ. 2020;368:l6669.
    >> Share

    December 2019
  49. YU Y, Arah OA, Liew Z, Cnattingius S, et al
    Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up.
    BMJ. 2019;367:l6398.
    >> Share

    November 2019
  50. RODRIGUEZ-GUTIERREZ R, Gonzalez-Gonzalez JG, Zuniga-Hernandez JA, McCoy RG, et al
    Benefits and harms of intensive glycemic control in patients with type 2 diabetes.
    BMJ. 2019;367:l5887.
    >> Share

    October 2019
  51. MIRZAZADEH M, Alijani E, Fani M, Jamili S, et al
    A 44 year old woman with episodic sweating and hypertension.
    BMJ. 2019;367:l5879.
    >> Share

  52. SPILSBURY C, Panahi M, Bowsher G, Sadighi A, et al
    A young woman with dyspnoea and oedema.
    BMJ. 2019;367:l5763.
    >> Share

  53. IACOBUCCI G
    Diabetes technology: specialists are blocking access for some patients, say experts.
    BMJ. 2019;367:l6085.
    >> Share


  54. Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis.
    BMJ. 2019;367:l5612.
    >> Share

  55. IACOBUCCI G
    Thousands more patients with type 1 diabetes are getting flash glucose devices, data show.
    BMJ. 2019;367:l5895.
    >> Share

    September 2019
  56. HENDERSON G
    Whether one burns fat, and not the type of fat one eats, is the important thing in type 2 diabetes.
    BMJ. 2019;366:l5700.
    >> Share

  57. HOOPER L, Brown T, Brainard J, Abdelhamid A, et al
    Authors' reply to Henderson.
    BMJ. 2019;366:l5703.
    >> Share

  58. LEAN M, McCombie L, McSorely J
    Trends in type 2 diabetes.
    BMJ. 2019;366:l5407.
    >> Share

  59. MAGLIANO DJ, Islam RM, Barr ELM, Gregg EW, et al
    Trends in incidence of total or type 2 diabetes: systematic review.
    BMJ. 2019;366:l5003.
    >> Share

    August 2019
  60. PASTERNAK B, Ueda P, Eliasson B, Svensson AM, et al
    Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.
    BMJ. 2019;366:l4772.
    >> Share

  61. LIND M, Pivodic A, Svensson AM, Olafsdottir AF, et al
    HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study.
    BMJ. 2019;366:l4894.
    >> Share

  62. BROWN TJ, Brainard J, Song F, Wang X, et al
    Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials.
    BMJ. 2019;366:l4697.
    >> Share

  63. MAHASE E
    Progress in diabetes care has not improved outcomes in US, study finds.
    BMJ. 2019;366:l5166.
    >> Share

    July 2019
  64. MERINO J
    Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis.
    BMJ. 2019;366:l4292.
    >> Share

  65. NEUENSCHWANDER M, Ballon A, Weber KS, Norat T, et al
    Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies.
    BMJ. 2019;366:l2368.
    >> Share

  66. JIAO J, Liu G, Shin HJ, Hu FB, et al
    Dietary fats and mortality among patients with type 2 diabetes: analysis in two population based cohort studies.
    BMJ. 2019;366:l4009.
    >> Share

    June 2019
  67. WISE J
    The wrong diabetes: how C peptide testing might help.
    BMJ. 2019;365:l4352.
    >> Share

  68. SHEIKH Z, Akali A
    An unstable lump in the groin.
    BMJ. 2019;365:l2214.
    >> Share

    May 2019
  69. KARSLIOGLU FRENCH E, Donihi AC, Korytkowski MT
    Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients.
    BMJ. 2019;365:l1114.
    >> Share

    April 2019
  70. MAHASE E
    Dentists could help detect diabetes and cardiovascular disease during oral health checks.
    BMJ. 2019;365:l1870.
    >> Share

  71. BARRY E, Finnikin S
    A borderline HBA1c result.
    BMJ. 2019;365:l1361.
    >> Share

  72. WEI L, Lai EC, Kao-Yang YH, Walker BR, et al
    Incidence of type 2 diabetes mellitus in men receiving steroid 5alpha-reductase inhibitors: population based cohort study.
    BMJ. 2019;365:l1204.
    >> Share

  73. MUSSO G, Gambino R, Cassader M, Paschetta E, et al
    Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials.
    BMJ. 2019;365:l1328.
    >> Share

  74. BLAIR JC, McKay A, Ridyard C, Thornborough K, et al
    Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    BMJ. 2019;365:l1226.
    >> Share

    March 2019
  75. WISE J
    The BMJ Awards 2019: Diabetes Team of the Year.
    BMJ. 2019;364:l1232.
    >> Share

  76. IACOBUCCI G
    Sixty seconds on . . . reversing type 2 diabetes.
    BMJ. 2019;364:l1128.
    >> Share

  77. NEWMAN M
    Questions over future of global diabetes group as founding members resign.
    BMJ. 2019;364:l995.
    >> Share

    February 2019
  78. LEVY M, Prentice M, Wass J
    Diabetes insipidus.
    BMJ. 2019;364:l321.
    >> Share

  79. FEINMANN J
    Australian MPs visit Southport GP to learn about low carb diet for type 2 diabetes.
    BMJ. 2019;364:l659.
    >> Share

  80. SCIBILIA R, Aldred C
    #TalkAboutComplications.
    BMJ. 2019;364:k5258.
    >> Share

    January 2019
  81. KMIETOWICZ Z
    Fried food linked to increased risk of death among older US women.
    BMJ. 2019;364:l362.
    >> Share

  82. IACOBUCCI G
    Sixty seconds on . . . medical detection dogs.
    BMJ. 2019;364:l302.
    >> Share

  83. MAYOR S
    Delivering diabetes targets: five minutes with . . . Sam Everington.
    BMJ. 2019;364:l229.
    >> Share

  84. MANFREDINI R, Cappadona R, Fabbian F
    Nurses, shift work, and diabetes: should late chronotype be considered as a risk factor?
    BMJ. 2019;364:l178.
    >> Share

  85. SKOVENBORG E
    Shift work and diabetes: alcohol consumption as a risk factor.
    BMJ. 2019;364:l177.
    >> Share

  86. SHAN Z, Bhupathiraju SN
    Authors' reply to Skovenborg and Manfredini and colleagues.
    BMJ. 2019;364:l179.
    >> Share

  87. PILLING LC, Tamosauskaite J, Jones G, Wood AR, et al
    Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank.
    BMJ. 2019;364:k5222.
    >> Share

  88. MAYOR S
    Diabetes: precision approach will improve outcomes, says research director.
    BMJ. 2019;364:l186.
    >> Share

  89. SALISBURY H
    Helen Salisbury: When policy doesn't match evidence.
    BMJ. 2019;364:l54.
    >> Share

    December 2018
  90. CHARLTON M
    Everyone with type 1 diabetes should have access to a flash glucose device.
    BMJ. 2018;363:k5204.
    >> Share

  91. BLACK S
    Flash glucose monitoring devices: CCG criteria are incoherent.
    BMJ. 2018;363:k5203.
    >> Share

  92. ADLER AI
    Incretins and cancer of the bile duct in type 2 diabetes.
    BMJ. 2018;363:k5155.
    >> Share

  93. ABRAHAMI D, Douros A, Yin H, Yu OH, et al
    Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.
    BMJ. 2018;363:k4880.
    >> Share

    November 2018
  94. FEINMANN J
    Type 2 diabetes: 5000 patients to test feasibility of "remission service".
    BMJ. 2018;363:k5114.
    >> Share

  95. HENDLEY J
    Are you well controlled?
    BMJ. 2018;363:k3119.
    >> Share

  96. SHAN Z, Li Y, Zong G, Guo Y, et al
    Rotating night shift work and adherence to unhealthy lifestyle in predicting risk of type 2 diabetes: results from two large US cohorts of female nurses.
    BMJ. 2018;363:k4641.
    >> Share

  97. IACOBUCCI G
    Type 2 diabetes affects 7000 young people in England and Wales, analysis shows.
    BMJ. 2018;363:k4929.
    >> Share

  98. KMIETOWICZ Z
    Type 2 diabetes: sweetened drinks pose greater risk than other sugary foods.
    BMJ. 2018;363:k4943.
    >> Share

  99. CHOO VL, Viguiliouk E, Blanco Mejia S, Cozma AI, et al
    Food sources of fructose-containing sugars and glycaemic control: systematic review and meta-analysis of controlled intervention studies.
    BMJ. 2018;363:k4644.
    >> Share

  100. SODI R, McKay K, Dampetla S, Pappachan JM, et al
    Monitoring glycaemic control in patients with diabetes mellitus.
    BMJ. 2018;363:k4723.
    >> Share

  101. KMIETOWICZ Z
    SGLT2 inhibitors for diabetes are linked to increased risk of lower limb amputation.
    BMJ. 2018;363:k4828.
    >> Share

  102. UEDA P, Svanstrom H, Melbye M, Eliasson B, et al
    Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.
    BMJ. 2018;363:k4365.
    >> Share

  103. IACOBUCCI G
    NHS England tells CCGs to end postcode lottery over diabetes glucose devices.
    BMJ. 2018;363:k4812.
    >> Share

  104. OWEN J
    Audit paints "bleak picture" of diabetes care in England and Wales.
    BMJ. 2018;363:k4780.
    >> Share

  105. IACOBUCCI G
    Patients with type 1 diabetes are missing out on flash glucose devices, finds BMJ investigation.
    BMJ. 2018;363:k4675.
    >> Share

  106. MILLETT ERC, Peters SAE, Woodward M
    Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants.
    BMJ. 2018;363:k4247.
    >> Share

    October 2018
  107. KHANDWALA YS, Baker VL, Shaw GM, Stevenson DK, et al
    Association of paternal age with perinatal outcomes between 2007 and 2016 in the United States: population based cohort study.
    BMJ. 2018;363:k4372.
    >> Share

    September 2018
  108. MIETTINEN ME, Virtanen SM
    Dietary gluten and type 1 diabetes.
    BMJ. 2018;362:k3867.
    >> Share

  109. ANTVORSKOV JC, Halldorsson TI, Josefsen K, Svensson J, et al
    Association between maternal gluten intake and type 1 diabetes in offspring: national prospective cohort study in Denmark.
    BMJ. 2018;362:k3547.
    >> Share

  110. RAMOS R, Comas-Cufi M, Marti-Lluch R, Ballo E, et al
    Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
    BMJ. 2018;362:k3359.
    >> Share

  111. XU G, Liu B, Sun Y, Du Y, et al
    Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study.
    BMJ. 2018;362:k1497.
    >> Share

    August 2018
  112. MAYOR S
    Type 1 diabetes: earlier onset is linked to cardiovascular complications and reduced lifespan.
    BMJ. 2018;362:k3487.
    >> Share

  113. WISE J
    Diabetes: simple patient characteristics should help inform choice of second line drug, study finds.
    BMJ. 2018;362:k3368.
    >> Share

    July 2018
  114. MCGOWAN LD, Roumie CL
    Sulfonylureas as second line treatment for type 2 diabetes.
    BMJ. 2018;362:k3041.
    >> Share

  115. DOUROS A, Dell'Aniello S, Yu OHY, Filion KB, et al
    Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.
    BMJ. 2018;362:k2693.
    >> Share

  116. FEGHALI MN, Scifres CM
    Novel therapies for diabetes mellitus in pregnancy.
    BMJ. 2018;362:k2034.
    >> Share

  117. LUDVIGSSON JF, Neovius M, Soderling J, Gudbjornsdottir S, et al
    Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden.
    BMJ. 2018;362:k2638.
    >> Share

    June 2018
  118. ABALEM MF, Eagle KA, Rao RC
    Unilateral retinopathy in a patient with diabetes and coronary heart disease.
    BMJ. 2018;361:k1703.
    >> Share

  119. FOROUHI NG, Misra A, Mohan V, Taylor R, et al
    Dietary and nutritional approaches for prevention and management of type 2 diabetes.
    BMJ. 2018;361:k2234.
    >> Share

    May 2018
  120. DOBSON R, Whittaker R, Jiang Y, Maddison R, et al
    Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial.
    BMJ. 2018;361:k1959.
    >> Share

    April 2018
  121. CARRUTH L, Mendenhall E
    Social aetiologies of type 2 diabetes.
    BMJ. 2018;361:k1795.
    >> Share

  122. STAERK L, Wang B, Preis SR, Larson MG, et al
    Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.
    BMJ. 2018;361:k1453.
    >> Share

  123. WAUGH N, Adler A, Craigie I, Omer T, et al
    Closed loop systems in type 1 diabetes.
    BMJ. 2018;361:k1613.
    >> Share

  124. BEKIARI E, Kitsios K, Thabit H, Tauschmann M, et al
    Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.
    BMJ. 2018;361:k1310.
    >> Share

    March 2018
  125. STRINGHINI S, Carmeli C, Jokela M, Avendano M, et al
    Socioeconomic status, non-communicable disease risk factors, and walking speed in older adults: multi-cohort population based study.
    BMJ. 2018;360:k1046.
    >> Share

  126. HAWKES N
    Sixty seconds on . . . diabetes.
    BMJ. 2018;360:k1264.
    >> Share

  127. ABRAHAMI D, Douros A, Yin H, Yu OHY, et al
    Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.
    BMJ. 2018;360:k872.
    >> Share

  128. WISE J
    NHS diabetes prevention programme helps weight loss, analysis shows.
    BMJ. 2018;360:k1196.
    >> Share

    February 2018
  129. PATORNO E, Goldfine AB, Schneeweiss S, Everett BM, et al
    Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study.
    BMJ. 2018;360:k119.
    >> Share

  130. MORLEY RL, Sharma A, Horsch AD, Hinchliffe RJ, et al
    Peripheral artery disease.
    BMJ. 2018;360:j5842.
    >> Share

    January 2018
  131. TU H, Wen CP, Tsai SP, Chow WH, et al
    Cancer risk associated with chronic diseases and disease markers: prospective cohort study.
    BMJ. 2018;360:k134.
    >> Share

  132. WISE J
    NHS weight management programme makes clinical difference in patients with type 2 diabetes.
    BMJ. 2018;360:k177.
    >> Share

  133. WENG J, Zhou Z, Guo L, Zhu D, et al
    Incidence of type 1 diabetes in China, 2010-13: population based study.
    BMJ. 2018;360:j5295.
    >> Share

    December 2017
  134. KMIETOWICZ Z
    GP based weight loss programme can reverse type 2 diabetes.
    BMJ. 2017;359:j5641.
    >> Share

  135. WISE J
    Study links varicoceles to heart disease and diabetes.
    BMJ. 2017;359:j5569.
    >> Share

    November 2017
  136. HIPPISLEY-COX J, Coupland C
    Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    BMJ. 2017;359:j5019.
    >> Share

  137. MISHRA SC, Chhatbar KC, Kashikar A, Mehndiratta A, et al
    Diabetic foot.
    BMJ. 2017;359:j5064.
    >> Share

  138. HAWKES N
    Sixty seconds on . . . semaglutide.
    BMJ. 2017;359:j5010.
    >> Share

    October 2017
  139. KALLIALA I, Markozannes G, Gunter MJ, Paraskevaidis E, et al
    Obesity and gynaecological and obstetric conditions: umbrella review of the literature.
    BMJ. 2017;359:j4511.
    >> Share

  140. MAYOR S
    Type 3c diabetes associated with pancreatic disease is often misdiagnosed, finds study.
    BMJ. 2017;359:j4923.
    >> Share

  141. MAYOR S
    GP referral to prevention programme helps prevent type 2 diabetes, study finds.
    BMJ. 2017;359:j4770.
    >> Share

  142. MARJOT D
    Hunger can be the driving force behind "relapse" of type 2 diabetes.
    BMJ. 2017;359:j4728.
    >> Share

  143. COUSINS S
    Diabetic patients with poor glycaemic control have higher risk of latent TB, study shows.
    BMJ. 2017;359:j4767.
    >> Share

    September 2017
  144. MAYOR S
    Obesity surgery achieves long term weight loss and prevents type 2 diabetes, study finds.
    BMJ. 2017;358:j4376.
    >> Share

  145. GULLAND A
    People at high risk of diabetes should undergo intensive lifestyle change, says NICE.
    BMJ. 2017;358:j4301.
    >> Share

  146. MAYOR S
    Twenty four hour glucose monitoring halves adverse birth outcomes in pregnant women with type 1 diabetes, study finds.
    BMJ. 2017;358:j4294.
    >> Share

  147. MCCOMBIE L, Leslie W, Taylor R, Kennon B, et al
    Beating type 2 diabetes into remission.
    BMJ. 2017;358:j4030.
    >> Share

  148. DYER O
    France to prosecute its drug regulator and Servier in scandal over diabetes drug.
    BMJ. 2017;358:j4231.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016